During the past decade, Partners Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Partners Research" #1 collaborator was "Glaxo Wellcome" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Partners Research" are "HIV Infections" (7 trials), "HIV Wasting Syndrome" (1 trials), "Mycobacterium Avium-intracellulare Infection" (1 trials), "Peripheral Nervous System Disease" (1 trials) and "Pneumonia, Pneumocystis Carinii" (1 trials). Many other conditions were trialed in "Partners Research" in a lesser frequency.

Most popular intervention types in "Partners Research" are "Drug" (4 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amitriptyline hydrochloride" (1 trials), "Amitriptyline hydrochloride placebo" (1 trials), "Clarithromycin" (1 trials), "Clofazimine" (1 trials) and "Ethambutol hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Partners Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Partners Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Partners Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Partners Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".